Pieris Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Pieris Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 65% to $42,810,000. The net income raised on -$24,543,000 and profit margin reached -57%. Total operating expenses were $72,566,000.
Profit Margin
| 2014 | 5.36M | -9.84M | -183.59% |
|---|---|---|---|
| 2015 | 2.93M | -14.05M | -479.5% |
| 2016 | 5.83M | -22.79M | -391.02% |
| 2017 | 25.27M | -17.64M | -69.82% |
| 2018 | 29.10M | -26.75M | -91.93% |
| 2019 | 46.27M | -23.75M | -51.33% |
| 2020 | 29.32M | -37.23M | -126.97% |
| 2021 | 31.41M | -43.36M | -138.03% |
| 2022 | 25.90M | -31.25M | -120.66% |
| 2023 | 42.81M | -24.54M | -57.33% |
PIRS Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 42.81M | 25.90M | 31.41M | 29.32M | 46.27M | 29.10M | 25.27M | 5.83M | 2.93M | 5.36M |
Cost of revenue | 41.80M | 2.78M | 2.36M | 46.53M | 54.99M | 0 | 0 | 0 | 0 | 0 |
Gross profit | 1.00M | 23.12M | 29.05M | -17.20M | -8.71M | 29.10M | 25.27M | 5.83M | 2.93M | 5.36M |
Operating exp. | ||||||||||
Research and development | 41.80M | 52.98M | 66.65M | 46.53M | 54.99M | 41.49M | 22.28M | 19.69M | 8.24M | 5.60M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 72.56M | 61.20M | 79.56M | 63.24M | 73.43M | 59.93M | 39.86M | 28.58M | 16.61M | 12.56M |
Operating income | -29.75M | -43.47M | -51.83M | -33.92M | -27.15M | -30.83M | -14.59M | -22.75M | -13.68M | -7.19M |
Other income (expenses), net | 5.21M | 10.19M | 6.09M | -3.14M | 1.68M | 3.76M | -1.95M | 119.50K | -173.74K | -2.65M |
Income before tax | -24.54M | -33.27M | -45.73M | -37.06M | -25.46M | -27.06M | -16.54M | -22.63M | -13.85M | -9.84M |
Income tax expense | 0 | -2.02M | -2.37M | 164K | -1.71M | -312K | 1.10M | 161.97K | 203.86K | -18 |
Net income | -24.54M | -31.25M | -43.36M | -37.23M | -23.75M | -26.75M | -17.64M | -22.79M | -14.05M | -9.84M |
Earnings per share | ||||||||||
Basic EPS | -21.8 | -33.71 | -53.75 | -54.67 | -37.54 | -40.32 | -32.14 | -43.73 | -32.7 | -20.62 |
Diluted EPS | -21.8 | -33.71 | -53.75 | -54.67 | -37.54 | -40.32 | -32.14 | -43.73 | -32.7 | -20.62 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |